Copyright
©The Author(s) 2025.
World J Gastroenterol. Aug 7, 2025; 31(29): 105210
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.105210
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.105210
Figure 1 Receiver operating characteristic curve analysis of core-fucosylated low-molecular-weight kininogen and other biomarkers.
ROC: Receiver operating characteristic; AUC: Area under the curve; APRI: Aminotransferase-to-platelet ratio index; LMWK: Low-molecular-weight kininogen; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase.
Figure 2 Nomogram for low-molecular-weight kininogen and other biomarkers.
LMWK: Low-molecular-weight kininogen; APRI: Aminotransferase-to-platelet ratio index; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase.
Figure 3 Receiver operating characteristic curve analysis for the nomogram.
AUC: Area under the curve.
Figure 4 Clinical decision curve for the nomogram.
- Citation: Gao GF, Yu J, Tong L, Jiang D. Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study. World J Gastroenterol 2025; 31(29): 105210
- URL: https://www.wjgnet.com/1007-9327/full/v31/i29/105210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i29.105210